Added Value of Xpert MTB/RIF Ultra for Diagnosis of Pulmonary Tuberculosis in a Low-Prevalence Setting

Onya Opota(University Hospital of Lausanne), Fathiah Zakham(University Hospital of Lausanne), Jesica Mazza‐Stalder(University Hospital of Lausanne), Laurent Nicod(University Hospital of Lausanne), Gilbert Greub(University Hospital of Lausanne), Katia Jaton(University Hospital of Lausanne)
Journal of Clinical Microbiology
December 11, 2018
Cited by 70Open Access
Full Text

Abstract

= 196) in Lausanne (Switzerland). Clinical data were used to investigate discrepant results. Correlation between semiquantitative result of Ultra and smear microscopy status for the detection of acid-fast bacilli (AFB) was established. The sensitivities of Xpert and Ultra were 82.9% (39/47) and 95.8% (45/47), respectively, when considering all culture-positive specimens, 100% (23/23) for both assays on smear-positive specimens, and 66.7% (16/24) and 91.7% (22/24) on smear-negative specimens. Using culture as gold standard, the specificities of Xpert and Ultra were 97.3% (145/149) and 96.64% (144/149), respectively. All the patients with Ultra-positive results with the new category "trace" were diagnosed with active TB based on clinical findings and microbiological culture. The semiquantitative results of both Xpert and of Ultra positively correlated with the semiquantitative result of AFB detection. Our data support an increased sensitivity of Ultra compared to Xpert in a low-prevalence setting. Correlation between the Ultra semiquantitative result and AFB burden can help in evaluating a patient's transmission potential.


Related Papers

No related papers found

Powered by citation graph analysis